SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-056834
Filing Date
2018-11-01
Accepted
2018-11-01 17:01:48
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv504822_10q.htm 10-Q 822117
2 EXHIBIT 10.1 tv504822_ex10-1.htm EX-10.1 32147
3 EXHIBIT 31.1 tv504822_ex31-1.htm EX-31.1 7583
4 EXHIBIT 31.2 tv504822_ex31-2.htm EX-31.2 7574
5 EXHIBIT 32.1 tv504822_ex32-1.htm EX-32.1 5142
  Complete submission text file 0001144204-18-056834.txt   5989533

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT icpt-20180930.xml EX-101.INS 1795429
7 XBRL TAXONOMY EXTENSION SCHEMA icpt-20180930.xsd EX-101.SCH 36515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20180930_cal.xml EX-101.CAL 47271
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20180930_def.xml EX-101.DEF 105714
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20180930_lab.xml EX-101.LAB 298350
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20180930_pre.xml EX-101.PRE 256609
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 181154640
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1